Israel's scientists think big with the very, very small

A material just one atom thick that is stronger than steel but flexes like rubber. A "mini-submarine" that can trick the immune system and deliver a payload of chemotherapy deep inside a tumour.

The nanomechanical signature of breast cancer

The texture of breast cancer tissue differs from that of healthy tissue. Using a cutting-edge tissue diagnostic device, a group of researchers in Basel, Switzerland, has determined one key difference: cancerous tissue is ...

Blind mole-rats are resistant to chemically induced cancers

Like naked mole-rats (Heterocephalus gaber), blind mole-rats (of the genus Spalax) live underground in low-oxygen environments, are long-lived and resistant to cancer. A new study demonstrates just how cancer-resistant Spalax ...

Static killers?

Mammals contain cells whose primary function is to kill other cells in the body. The so-called Natural Killer (NK) cells are highly important in defending our bodies against viruses or even cancer. Scientists at the University ...

Nanoparticle therapeutic enhances cancer immunotherapy

Researchers at Wake Forest School of Medicine have discovered that a nanoparticle therapeutic enhances cancer immunotherapy and is a possible new approach in treating malignant pleural effusion (MPE). MPE is the accumulation ...

Ionizing radiation found to soften tumor cell microenvironment

Nearly half of all cancer patients receive radiation therapy to curb the growth of malignant cells. But little is known about how ionizing radiation affects the extracellular matrix (ECM), a patchwork of proteins and other ...

Self-assembling nanofilaments enhance drug delivery

(Phys.org)—While most nanoparticles under development as drug delivery vehicles are spheres, a growing body of research suggests that cylindrical nanoparticles would perform even better at the twin goal of surviving in ...

Enabling nanoparticles to penetrate deeply in tumors

Too often, researchers designing nanoparticles capable of delivering effective doses of anticancer agents to tumors must balance the need to choose a nanoparticle that is small enough to escape the leaky blood vessels that ...

page 6 from 13